News
Eli Lilly's growth is impressive, but its current valuation is only justifiable with sustained high growth. Click here to ...
Artedrone is trying to raise a €20 million Series B funding round to finalize its preclinical work and fund the ...
Insulet has shown impressive revenue and profit growth, driven by its Omnipod System and expanding global presence. Read more ...
MINNEAPOLIS, May 22, 2025 /PRNewswire/ -- Phraxis Inc., a Minneapolis-based medical device company, marks a major milestone with FDA approval ... promote laminar blood flow and reduce turbulent ...
NRXBF READ THE FULL NRXBF RESEARCH REPORT NurExone (OTC:NRXBF) is developing a product known as ExoPTEN that is designed to treat patients with acute spinal cord injuries, while also conducting ...
Fourth quarterIn constant exchange rates, net sales increased by 6 percent mainly driven by Europe and APAC. Reported sales increased by 3 percent amounting to SEK 5,156 M (5,023).Book-to-bill ratio o ...
The FDA has said it will expand unannounced inspections of overseas manufacturing facilities supplying medicine and other medical products to the US. The aim is to make sure that foreign companies ...
Mesa Laboratories, Inc. (NASDAQ:MLAB), a global leader in the design and manufacture of life science tools and critical quality control solutions, today ...
It said earlier this week that it would ask for a so-called 'Type A' meeting with the FDA, which is designed to chart the way forward for a failed application. Jaser said that the urgent need for ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Bad Bunny Last week Weeks at no. 1 Weeks on chart Rimas Week of May 24, 2025 click to see more Rimas American Dogwood/EMPIRE ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results